You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Tilt collaborates with MSD on immunotherapy clinical trial

Tilt Biotherapeutics – a clinical-stage biotechnology company developing cancer immunotherapies – has announced that it has signed a second clinical trial collaboration and supply agreement with MSD, a trade name of Merck.